InvestorsHub Logo
Followers 229
Posts 21432
Boards Moderated 2
Alias Born 08/03/2006

Re: None

Thursday, 05/11/2017 7:12:41 AM

Thursday, May 11, 2017 7:12:41 AM

Post# of 8422
SYN-004 (Ribaxamase) Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Prevention of Clostridium difficile Infection

http://ir.syntheticbiologics.com/press-releases/detail/239/syn-004-ribaxamase-receives-breakthrough-therapy


Yeah baby!

"Perfection is not attainable, but if we chase perfection we can catch
excellence." Vince Lombardi
Do your research! Play the TA. All posts are my opinion.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TOVX News